Published by ChinaMNC · Shuifu

Yunnan’s 15th Five-Year Plan for Traditional Chinese Medicine Herbs: What Foreign Founders Need to Know

A practical English-language summary of Yunnan Province’s planned changes to its traditional Chinese medicine herb industry through 2030, written for foreign founders evaluating registration or operations in China.

Yunnan’s Herb Sector Plan at a Glance

Yunnan Province has published a notice on its “15th Five-Year Plan” for the development of the traditional Chinese medicine (TCM) herb industry. For foreign founders considering a China-registered company in agriculture, processing, health products or related supply chains, the plan signals where provincial policy attention and support are likely to go through 2030.

The headline direction is a deliberate shift: by 2030, the expected planted area for TCM herbs is to fall by 1.608 million mu, while the target for comprehensive output value is to rise by 50 billion yuan. In short, the province intends to trade planted area for gains in quality, processing, branding and economic returns.

What Is Being Grown

Priority herb categories

Building on the 156 varieties listed in the Yunnan Provincial Dao-di Herbs Catalogue (2024 Edition), the plan sets out three priority groups:

• Dao-di advantage varieties, led by the “Ten Major Yunnan Herbs,” with Panax notoginseng (sanqi) as the representative example.
• Health-oriented specialty varieties, centred on the “Ten Major Health Resources.”
• Potential cultivation varieties, represented by the “Six Major Southern Medicines.”

The source names the “Ten Major Yunnan Herbs” as sanqi, Yunnan Paris polyphylla (Dian chonglou), Erigeron breviscapus (dengzhanhua), Dendrobium officinale (tiepi shihu), amomum (sharen), gastrodia (tianma), Yunnan poria (yun fuling), Yunnan angelica (yun danggui), Yunnan costus (yun muxiang) and Yunnan gentian (Dian longdan).

It lists the “Ten Major Health Resources” as Yunnan polygonatum (Dian huangjing), safflower (honghua), bletilla (baiji), purple-skin dendrobium, emblica (Dian ganlan), coix seed (yiyiren), terminalia chebula (hezi), tsaoko (caoguo), ginger and star anise.

The “Six Major Southern Medicines” are given as amomum, dragon’s blood (longxuejie), cibotium (gouji), agarwood (chenxiang), clerodendranthus (shencha) and Dai bai jie.

How Cultivation Is Being Standardised

GAP bases and national-level production

The plan aims to establish 200 TCM herb GAP (Good Agricultural Practice) bases. A key focus is full GAP coverage for Wenshan sanqi. The province also intends to advance GAP bases in an orderly way for under-forest varieties such as poria, amomum, tsaoko and phellodendron (huangbo), and to compete for a number of national-level high-standard TCM herb raw material production bases.

Under-forest cultivation

Focusing on dao-di herbs including sanqi, gastrodia, poria, amomum, polygonatum and phellodendron, the plan promotes under-forest cultivation and breeding of TCM herbs. Ecological and under-forest planting bases are to expand to more than 6 million mu.

Processing and Higher-Value Products

Primary processing at production sites

The plan supports setting up production-origin processing lines in dao-di herb production areas and at high-standard TCM raw material production bases. It also seeks to link GAP-base herbs with fresh-cut processing, and to upgrade products from primary raw materials to semi-industrialised input materials.

Deep processing and health products

Enterprises are encouraged to build modern deep-processing lines and develop higher value-added products, forming a series of Yunnan herb health products. The plan also promotes research, development and industrialisation of health products in areas such as daily chemicals and cosmetics, and functional wellness products.

Market Stability and Risk Warnings

The plan addresses market volatility for major and scarce varieties that are easily affected by market swings, specifically naming sanqi, angelica (danggui) and Paris polyphylla (chonglou). It calls for adjustment through market-based methods to smooth fluctuations, and for an information monitoring and early-warning system to flag industry risks such as “blind expansion of planting” and “low herb prices hurting farmers.”

Food-Medicine Homology and Cross-Border Registration

Yunnan intends to formulate a series of standards, including quality standards for food-medicine homology raw materials and production and processing specifications. The plan also sets a target of completing cross-border registration and launch for 5 to 10 new products, and to plan a “Yunnan Herb Food-Medicine Homology Culture Festival.”

Digital and AI Applications

The province plans to implement a “Yunnan Herb Brain” artificial intelligence innovation application project. This would build an intelligent application system covering the full life cycle of TCM herbs, and promote multi-level, multi-scenario intelligent solutions in key areas of the sector.

Practical Takeaways for Foreign Founders

• Quality over volume: policy direction favours standardised, higher-quality production and processing rather than simple area expansion.
• Priority categories matter: the named herb groups indicate where provincial attention is concentrated.
• Processing is a focus: production-origin processing and deep processing for higher value-added products are explicitly supported.
• Compliance and standards: GAP bases, food-medicine homology standards and cross-border product registration are areas to watch when planning products or partnerships.
• Market monitoring: early-warning systems for oversupply and price risks may affect sourcing and investment decisions.

Foreign founders should treat this plan as a policy signal rather than a set of automatic entitlements. Specific licensing, land use, agricultural investment, product registration and tax treatment depend on the applicable laws, local implementation rules and the structure of any China-registered entity. Professional advice should be obtained before committing capital.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.